Yarrow Bioscience

Yarrow Bioscience

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$97
$86
$130
Gross Profit
91
80
130
EBITDA
-9,724
-2,893
-3,579
-4,951
EBIT
-10,743
-2,899
-3,585
-4,956
Net Income
-9,724
-3,007
-3,585
-4,837
Net Change In Cash
0
97
86
130
Free Cash Flow
-89,957
-1,992
-4,081
-3,764
Cash
268,860
22,925
24,631
24,027
Basic Shares
22,593
858
855
666

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$570
$501
$424
$477
Gross Profit
547
501
424
477
EBITDA
-26,709
-39,799
-27,872
-33,860
EBIT
-26,732
-39,803
-33,932
Net Income
-26,483
-39,834
-28,452
-23,210
Net Change In Cash
570
501
424
477
Free Cash Flow
-33,124
-34,089
-25,341
-29,200
Cash
24,027
19,926
30,620
30,908
Basic Shares
855
851
205
63

Earnings Calls

QuarterEPS
2026-09-30
-$0.43
2026-06-30
-$2.14
2026-03-31
-$4.19
2025-09-30
-$8.50